93483-71-7Relevant articles and documents
VASCULAR ADHESION PROTEIN-1 (VAP-1) MODULATORS AND THERAPEUTIC USES THEREOF
-
, (2020/01/24)
Disclosed herein are small molecule Vascular Adhesion Protein- 1 (VAP-1) modulator compositions, pharmaceutical compositions, the use and preparation thereof.
Synthesis and antitumor activity of novel phenylhydrazonopyrazolone derivatives and molecular dynamics simulations
Hu, Xia-min,Cui, Zhi-wen,Dong, Wei,Zhu, Yue,Gao, Cheng-zhi,Xu, Shi-qiang,Yuan, Qiong,Yu, Zhi-jun,Min, Zhen-li
, p. 5107 - 5122 (2018/04/05)
SHP2 is a new promising target for anti-cancer drug discovery. A series of novel phenylhydrazonopyrazolone derivatives was synthesized by a more convenient method, and their chemical structures were characterized by various spectroscopic methods. The inhibitory effects of these compounds on SHP2 enzyme and SHP2-dependent cancer cell H1975 were evaluated. The compound 11f with IC50 value of 3.38?μmol/L exhibited more potent antitumor activity against H1975 cell than GS-493 (IC50 = 20.92?μmol/L). Molecular dynamics simulation of compound 11f displayed a possible mode of interaction between this compound and SHP2 enzyme.
Design, synthesis, and insecticidal evaluation of new benzoylureas containing amide and sulfonate groups based on the sulfonylurea receptor protein binding site for diflubenzuron and glibenclamide
Sun, Ranfeng,Wang, Ziwen,Li, Yongqiang,Xiong, Lixia,Liu, Yuxiu,Wang, Qingmin
, p. 517 - 522 (2013/03/14)
On the basis of the sulfonylurea receptor (SUR) protein binding site for diflubenzuron and glibenclamide, 15 new benzoylphenylureas containing amide and sulfonate groups were designed and synthesized. Their structures were characterized by 1H n